TamirBio Overview

  • Founded
  • 1981
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 5
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $21.5M
Latest Deal Amount

TamirBio General Information

Description

Provider of innovative therapeutics drugs intended to treat human viral diseases. The company's therapeutics drugs develop therapies for the treatment of human viral diseases and are discovered and developed as a new class of prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions, enabling clinicians to get the required antiviral drug to treat various viral infections and provide improved results to their patients.

Contact Information

Formerly Known As
Alfacell
Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • 51 JFK Parkway
  • 1st Floor West, Suite 108
  • Short Hills, NJ 07078
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TamirBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 23-Apr-2020 $21.5M 000.00 000.00 Completed Generating Revenue
8. Angel (individual) 25-Jan-2018 00000 000.00 Completed Generating Revenue
7. Angel (individual) 29-Dec-2016 00.000 000.00 Completed Generating Revenue
6. Angel (individual) 19-May-2014 00000 000.00 Completed Generating Revenue
5. Angel (individual) 27-Dec-2012 000 000.00 Completed Generating Revenue
4. Mezzanine 28-Oct-2009 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 27-Jul-2006 000.00 000.00 Completed Generating Revenue
2. Angel (individual) 19-May-2004 $10M $13M Completed Generating Revenue
1. Angel (individual) 12-Feb-2004 $3M $3M Completed Generating Revenue
To view TamirBio’s complete valuation and funding history, request access »

TamirBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial